Transcriptomic profile comparison of monocytes from rheumatoid arthritis patients in treatment with methotrexate, anti-TNFa, abatacept or tocilizumab.
It is well documented that patients affected by rheumatoid arthritis (RA) have distinct susceptibility to the different biologic DMARDs available on the market, probably because of the many facets of the disease. Monocytes are deeply involved in the pathogenesis of RA and we therefore evaluated and...
Main Authors: | Maria Talmon, Marcella Percio, Joyce Afrakoma Obeng, Federico A Ruffinatti, Daniele Sola, Pier Paolo Sainaghi, Emanuela Bellis, Stefano Cusinato, Aurora Ianniello, Luigia G Fresu |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2023-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0282564 |
Similar Items
-
Transcriptomic profile comparison of monocytes from rheumatoid arthritis patients in treatment with methotrexate, anti-TNFa, abatacept or tocilizumab
by: Maria Talmon, et al.
Published: (2023-01-01) -
Comparing the effectiveness and safety of Abatacept and Tocilizumab in elderly patients with rheumatoid arthritis.
by: Jumpei Temmoku, et al.
Published: (2022-01-01) -
Comparing the effectiveness and safety of Abatacept and Tocilizumab in elderly patients with rheumatoid arthritis
by: Jumpei Temmoku, et al.
Published: (2022-01-01) -
Compared efficacy of rituximab, abatacept, and tocilizumab in patients with rheumatoid arthritis refractory to methotrexate or TNF inhibitors agents: a systematic review and network meta-analysis
by: Alisson Pugliesi, et al.
Published: (2023-07-01) -
Different Contribution of Monocyte- and Platelet-Derived Microvesicles to Endothelial Behavior
by: Marta Brambilla, et al.
Published: (2022-04-01)